tiprankstipranks
Immunicum AB (DE:1YG0)
:1YG0
Germany Market

Immunicum AB (1YG0) Income Statement

Compare
1 Followers

Immunicum AB Income Statement

Last quarter (Q3 2022), Immunicum AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Immunicum AB's net income was $-38.60M. See Immunicum AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ 71.19K
EBITDA
$ -128.28M$ -84.25M$ -44.86M$ -97.85M$ -80.06M
Operating Income
$ -129.28M$ -85.96M$ -44.87M$ -96.54M$ -80.70M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -133.41M$ -89.25M$ -47.77M$ -97.86M$ -80.34M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Immunicum AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis